Mr. Wei  Zhao
My Social Links

Mr. Wei Zhao

Medical Professional
Shanghai Shuguang Hospital, China


Highest Degree
Ph.D. Student in Biomolecular Science from Saga University, Saga, Japan

Share this Profile

Area of Interest:

Biomedical Sciences
100%
Cardiovascular Medicine
62%
Heart Failure
90%
Hypertension
75%
Coronary Heart Disease
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Zhao, W., W. Hu, X. Wang, N. Xia, Q. Hu and H. Zhou, 2015. A traditional Chinese medicine, Lujiao prescription, as a potential therapy for hypertrophic cardiomyocytes by acting on histone acetylation. J. Chin. Med. Assoc., 78: 486-493.
    CrossRef  |  PubMed  |  Direct Link  |  
  2. Zhao, W., H. Soejima, T. Nakagawachi, T. Urano and S. Kudo et al., 2005. The essential role of histone H3 Lys9 Di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island. J. Biochem., 137: 431-440.
    CrossRef  |  PubMed  |  Direct Link  |  
  3. Soejima, H., W. Zhao and T. Mukai, 2005. Epigenetic silencing of the MGMT gene in cancer. Biochem. Cell. Biol., 83: 429-437.
    CrossRef  |  PubMed  |  Direct Link  |  
  4. Soejima, H., T. Nakagawachi, W. Zhao, K. Higashimoto and T. Urano et al., 2004. Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer. Oncogene, 23: 4380-4388.
    CrossRef  |  PubMed  |  Direct Link  |  
  5. Nakagawachi, T., H. Soejima, T. Urano, W. Zhao and K. Higashimoto et al., 2003. Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer. Oncogene, 22: 8835-8844.
    CrossRef  |  PubMed  |  Direct Link  |